Citalopram EP Impurity E HCl CAS 64169-47-7
| CAS No. | 64169-47-7 |
| Molecular Formula | C19H21ClFNO |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Compared with other compounds in its class, the molecular weight of 370.29 g/mol gives Citalopram EP Impurity E HCl distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
CATO supplies Citalopram EP Impurity E HCl (CAS 64169-47-7), a pharmacopoeial impurity reference standard (molecular formula C19H21ClFNOHCl, MW 370.29 g/mol) used for the identification and quantification of trace impurities in APIs.
Owing to a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine/chlorine substitution, Citalopram EP Impurity E HCl is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 370.29 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C19H21ClFNO HCl |
| Molecular Weight | 370.29 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1975 |
| Halogen Content | F/Cl-containing |
| Nitrogen Atoms | 1 |
Related Citalopram Standards
- Citalopram Impurity 38 (CAS 103146-26-5)
- Citalopram Impurity 17 (CAS 1187671-15-3)
- Citalopram EP Impurity D HBr (CAS 1188264-72-3)
- Citalopram-d6 N-Oxide (CAS 1189652-54-7)
- Citalopram-d6 (CAS 1190003-26-9)
- (R)-Citalopram-d6 N-Oxide (CAS 1217669-62-9)
- (S)-Citalopram-d6 N-Oxide (CAS 1217710-65-0)
- (S)-Citalopram-d6 Oxalate (CAS 1217733-09-9)
Recommended Standards
- Ponatinib Impurity 13 (CAS CATO-C4X-226913)
- Methylergometrine Impurity 1 (CAS 5516-91-6)
- Temocapril oxidation impurity (CAS CATO-C4X-34982)
- 4-(Difluoromethoxy)-3,5-dimethylbenzaldehyde (CAS 749920-58-9)
- 4-Ethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (CAS 1448869-99-5)
- (S)-2-(((1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)methyl)(cyclopropyl)amino)acetic acid (CAS 1354020-15-7)
- Ethyl 3-(3,4-dimethoxybenzoyl)-7-methylindolizine-1-carboxylate (CAS 853334-55-1)
- 2-Propenoic acid, polymer with ethene, compd. with morpholine (CAS 100684-91-1)
- 1,2-Dimethoxy-12-methyl-[1,3]dioxolo-[4,5:4,5]benzo[1,2-c]phenanthridin-12-ium (CAS 478-03-5)
- Neuropeptide SF (human) (CAS 192387-39-6)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com